Journal ArticleDOI
Prebiopsy Magnetic Resonance Imaging and Prostate Cancer Detection: Comparison of Random and Targeted Biopsies
Nicolas Barry Delongchamps,Michaël Peyromaure,A. Schull,Frédéric Beuvon,Naïm Bouazza,Thierry Flam,Marc Zerbib,Naira Muradyan,Paul Legman,François Cornud +9 more
TLDR
When performed with computerized magnetic resonance imaging-transrectal ultrasound image registration, targeted biopsy alone improved cancer detection over random biopsies, decreased the detection rate of microfocal cancer and increased the Detection rate of cancer with a Gleason score of greater than 6.About:
This article is published in The Journal of Urology.The article was published on 2013-02-01. It has received 249 citations till now. The article focuses on the topics: Magnetic resonance imaging & Prostate cancer.read more
Citations
More filters
Journal ArticleDOI
Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use
Jelle O. Barentsz,Jeffrey C. Weinreb,Sadhna Verma,Harriet C. Thoeny,Clare M. Tempany,Faina Shtern,Anwar R. Padhani,Daniel Margolis,Katarzyna J. Macura,Masoom A. Haider,François Cornud,Peter L. Choyke +11 more
TL;DR: This poster presents a probabilistic procedure to characterize the X-ray diffraction-gauging activity of the nucleus of the Tournaisian nervous system and its role in earthquake-triggered landsliding.
Journal ArticleDOI
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging–Ultrasound Fusion Targeted Biopsy: A Systematic Review
Massimo Valerio,Massimo Valerio,Massimo Valerio,Ian Donaldson,Mark Emberton,Mark Emberton,Behfar Ehdaie,Boris Hadaschik,Leonard S. Marks,Pierre Mozer,Ardeshir R. Rastinehad,Hashim U. Ahmed,Hashim U. Ahmed +12 more
TL;DR: Software-based MRI-US fusion targeted biopsy seems to detect more clinically significant cancers deploying fewer cores than standard biopsy, although further high-quality evidence is needed to change current practice.
Journal ArticleDOI
Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
O. Wegelin,Harm H.E. van Melick,Lotty Hooft,J.L.H. Ruud Bosch,Hans B. Reitsma,Jelle O. Barentsz,Diederik M. Somford +6 more
TL;DR: It is shown that magnetic resonance imaging-guided biopsy detects more clinically significant prostate cancer (PCa) and less insignificant PCa compared with systematic biopsy in men at risk for PCa.
Journal ArticleDOI
Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer
Frankâ€Jan H Drost,Daniël F Osses,Daan Nieboer,Ewout W. Steyerberg,Chris H. Bangma,Monique J. Roobol,Ivo G. Schoots +6 more
TL;DR: The diagnostic accuracy of the index tests MRI only, MRI-targeted biopsy, the MRI pathway and systematic biopsy as compared to template-guidedBiopsy as the reference standard in detecting clinically significant prostate cancer as the target condition was determined.
Journal ArticleDOI
Computer-Aided Detection and diagnosis for prostate cancer based on mono and multi-parametric MRI
Guillaume Lemaitre,Robert Martí,Jordi Freixenet,Joan C. Vilanova,Paul Walker,Fabrice Meriaudeau +5 more
TL;DR: This survey aims to provide a comprehensive review of the state-of-the-art in this lapse of time, focusing on the different stages composing the work-flow of a computer-aided system.
References
More filters
Journal ArticleDOI
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schröder,Jonas Hugosson,Monique J. Roobol,Stefano Ciatto,Vera Nelen,Maciej Kwiatkowski,Marcos Lujan,Hans Lilja,Marco Zappa,Louis Denis,Franz Recker,A. Berenguer,Liisa Määttänen,Chris H. Bangma,Gunnar Aus,Arnauld Villers,Xavier Rebillard,Theodorus van der Kwast,Bert G. Blijenberg,Sue Moss,Harry J. de Koning,Anssi Auvinen +21 more
TL;DR: PSA-based screening reduced the rate of death from prostate cancer by 20% but was associated with a high risk of overdiagnosis.
Journal ArticleDOI
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.
Paul S. Tofts,Gunnar Brix,David L. Buckley,Jeffrey L. Evelhoch,Elizabeth Henderson,Michael V. Knopp,Henrik Larsson,Ting-Yim Lee,Nina A. Mayr,Geoffrey J. M. Parker,Ruediger E. Port,June S. Taylor,Robert M. Weisskoff +12 more
TL;DR: A standard set of quantity names and symbols related to the estimation of kinetic parameters from dynamic contrast‐enhanced T1‐weighted magnetic resonance imaging data, using diffusable agents such as gadopentetate dimeglumine (Gd‐DTPA), are described.
Journal ArticleDOI
ESUR prostate MR guidelines 2012
Jelle O. Barentsz,Jonathan Richenberg,R. Clements,Peter L. Choyke,Sadhna Verma,Geert Villeirs,Olivier Rouvière,Vibeke Løgager,Jurgen J. Fütterer +8 more
TL;DR: Clinical indications, and minimal and optimal imaging acquisition protocols are provided, and a structured reporting system (PI-RADS) is described.
Journal ArticleDOI
Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
TL;DR: Serum PSA level, PSA density, and needle biopsy pathologic findings are accurate predictors of tumor extent and it may be reasonable to follow up some patients whose tumors are most likely insignificant with serial PSA measurements and repeated biopsies.
Journal ArticleDOI
Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer.
Thomas A. Stamey,Fuad S. Freiha,John E. McNeal,Elise A. Redwine,Alice S. Whittemore,Hans-Peter Schmid +5 more
TL;DR: The authors calculated the probability at birth of having a diagnosis of prostate cancer within a man's life to be 8.8% and subtracted the incidence of microscopic Stage A cancers too small to ever be clinically significant.